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UVB-Induced Melanocyte Proliferation in
Neonatal Mice Driven by CCR2-Independent
Recruitment of Ly6clowMHCIIhi Macrophages
Herlina Y. Handoko1,4, Mathieu P. Rodero2,4, Glen M. Boyle1, Blake Ferguson1, Christian Engwerda1,
Geoff Hill1, H. Konrad Muller3, Kiarash Khosrotehrani2,5 and Graeme J. Walker1,5
Intermittent sunburns, particularly in childhood, are the strongest environmental risk factor for malignant
melanoma (MM). In mice, a single neonatal UVR exposure induces MM, whereas chronic doses to adult mice do
not. Neonatal UVR alters melanocyte migration dynamics by inducing their movement upward out of hair
follicles into the epidermis. UVR is known to induce inflammation and recruitment of macrophages into the skin.
In this study, we have used a liposomal clodronate strategy to deplete macrophages at the time of neonatal UVR,
and have shown functionally that this reduces the melanocyte proliferative response. This effect was
not reproduced by depletion of CD11c-expressing populations of dendritic cells. On the basis of epidermal
expression array data at various time points after UVR, we selected mouse strains defective in various aspects of
macrophage recruitment, activation, and effector functions, and measured their melanocyte UVR response. We
identified Ly6clowMHCIIhi macrophages as the major population promoting the melanocyte response across
multiple strains. The activity of this subpopulation was CCR2 (C-C chemokine receptor type 2) independent and
partly IL-17 dependent. By helping induce this effect, the infiltration of specific macrophage subpopulations after
sunburn may be a factor in increasing the risk of subsequent neoplastic transformation of melanocytes.
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INTRODUCTION
Epidemiological studies clearly show that exposure of the skin
to UVR can increase one’s risk of developing malignant
melanoma (MM) (Gandini et al., 2005). Indeed, MM risk is
strongly associated with geographical location, with incidence
rates for white-skinned populations in regions of high UVR flux
at the highest risk (Whiteman and Green, 2005). Protection
from sun exposure with sunscreen can significantly reduce risk
(Green et al., 2011). However, the link between UVR and MM
is complex. Meta-analysis of all epidemiological studies that
assessed sun exposure and MM risk showed that MM
development is overwhelmingly influenced by intermittent
exposures (Gandini et al., 2005), particularly childhood
sunburns (Whiteman et al., 2001). This is in contrast to
epidermal keratinocyte-based skin cancers such as squamous
cell carcinoma, which is driven by cumulative UVR exposure
in a dose-dependent manner (Rigel, 2008). Hence, the
mechanisms that govern UVR-induced melanoma genesis
may be more complex than simply the induction and
accumulation of mutations through genotoxicity.
To study the mechanisms of UVR-induced melanoma genesis,
murine models prone to the development of the neoplasm are
commonly used. It is well known that a single relatively high-dose
UVB exposure to these neonatal mice is effective in inducing MM
in mice, whereas even chronic doses to adult mice are not
(Noonan et al., 2001; Hacker et al., 2005), mimicking the
epidemiological observations in humans. Mice are nocturnal
species, with most of their skin covered by fur. In adult mice,
melanocytes are almost confined to the hair follicle (except in the
ears and tail where they are occasionally found in the epidermis),
and melanin production is strictly coupled to anagen phase of hair
growth. However, in newborn murine skin, melanocytes are
present in the epidermis for the first week of life (Hirobe, 1984).
The regulation of melanocyte function within the skin and
hair follicle is complex, with potentially both local and
systemic factors at play, and melanocytes themselves may
even have a role in skin homeostasis (Slominski et al., 2004,
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2005; Plonka et al., 2009). Interestingly, in addition to the
activation of pigmentation pathways in melanocytes, UVR
exposure produces an increase in epidermal basal layer
melanocyte numbers in both humans and mice (Quevedo
et al., 1965; Stierner et al., 1989; Yamaguchi et al., 2008).
Increased numbers of melanocytes are observed around the
hair follicle outer root sheath in human skin that has been
exposed to chronic UVR (Staricco and Miller-Milinska, 1962).
As the increase in melanocyte number probably helps to
increase the total amount of melanin produced, this
proliferative response of melanocytes may be linked to,
although not necessary for, the tanning process. We
previously reported that neonatal mice have an exquisite
sensitivity to UVR-induced melanocyte proliferation and
migration, leading to a large increase in epidermal melano-
cyte numbers compared with untreated control skin (Walker
et al., 2009). Thus, notwithstanding the differences between
murine and human skin in terms of epidermal thickness and
the density of hair follicles, they provide a tractable system to
investigate the mechanisms of the melanocyte UVR response,
and also, using appropriate mouse models, to determine
whether this response is important for MM induction.
Keratinocytes have been suspected to have an important
role in the melanocyte response to UVR, as they can produce
many cytokines and growth factors that can evoke melanocyte
proliferation in cell culture. These include KITL, EDN1, bFGF,
HGF, LIF, PDGE2, GM-CSF, and Wnt ligands (Hirobe, 2005;
Rabbani et al., 2011), many of which are capable of
influencing both the melanocytic and immune systems. In
addition to its effect on keratinocytes, UVR-induced
inflammation may influence the melanocyte response. It has
long been known that macrophages enter the skin after
chronic or acute sun exposure. Meunier et al. (1995)
reported that macrophages increase in number over 2-fold in
the human dermis after a single sunburn. They appeared to be
derived from both transcapillary migration (i.e., recruitment)
and expansion of preexisting monocyte precursors in the
dermis. Aoki and Moro (2005) suggested that UVR-induced
inflammation could be driving melanocyte proliferation. Their
studies on chronic UVR-induced pigmented spots in hairless
mice led them to hypothesize that chemokines produced
in the skin attract inflammatory cells to the vicinity of
melanocytes, providing an interactive network and environ-
ment for melanocyte activation. The potential role for the
inflammatory response in driving melanocyte proliferation
response to UVR has been further highlighted by Zaidi et al.
(2011). In this case, macrophages were suspected to be the
origin of excess IFN-g production affecting melanocyte
proliferation.
Here we hypothesized that macrophages have a central role
in inducing melanocyte proliferation and/or migration to the
areas of skin exposed to UVR. In newborn mice, in which
UVB significantly exacerbates MM development, we have
used a macrophage depletion strategy to verify this, and have
identified Ly6clowMHCIIhi macrophages as the leading popu-
lation in promoting the melanocyte response. We determined
that the macrophage promotion of the melanocyte response is
not driven by classical inflammatory, but by ‘‘alternatively
activated’’ noninflammatory macrophages whose infiltration is
mostly CCR2 (C-C chemokine receptor type 2) independent.
By inducing melanocyte proliferation in response to UVR,
macrophages may have an important role in the early
processes involved in the initiation of MM.
RESULTS
Increase in epidermal melanocytes is concomitant with influx of
F4/80-positive monocytes
Newborn mice were irradiated with 5.9 kJ m2 UVB at 3 days
of age (P3), and the skin was harvested 4 days (D4) after UVR
(P7), representing the peak of melanocyte response according
to our previous findings (Walker et al., 2009) (Figure 1a).
A control group consisted of nonirradiated or shielded
littermates. Skin sections harvested at D4 (Figure 1b and c)
show a dense infiltrate of F4/80-positive monocytic cells in the
exposed skin and not in the shielded skin. These F4/80-
positive cells include Langerhans cells that, as expected, have
moved out of the epidermis by D4 in the exposed skin.
To detect melanocytes, skin sections were stained with an
anti-c-KIT antibody (Figure 1e and f). We used c-KIT because
it marks epidermal and follicular melanocytes at an earlier
state of differentiation than most pigmentation markers (see,
e.g., Grichnik et al., 1996; Sharov et al., 2003); hence, by
using c-KIT we are less likely to miss any relatively immature
cells in the epidermis. Notably, although c-KIT stains mast
cells and a subpopulation of keratinocytes in the lower hair
bulb (Peters et al., 2003), it does not stain epidermal
keratinocytes. The c-KIT-staining epidermal melanocytes that
we counted can be clearly differentiated from these other
cell types, and are consistent in shape and location as the
tyrosinase-related protein 1 and 2-positive cells that we
previously reported that increase in the epidermal basal
layer after neonatal UVR (Walker et al., 2009).
The numbers of melanocytes per mm2, with and without
UVR, can be seen in Figure 1g. In the shielded skin, almost no
melanocytes could be seen at the epidermal basal layer,
although they could be found in deeper areas of the hair
follicles. At D4, however, highly dendritic melanocytes can be
seen lining the permanent (upper) portion of the hair follicle
and the epidermal basal layer at a density of 55.25 (±1.35)
cells per mm2.
The phenotype of skin-infiltrating macrophages changes over
time
To investigate the makeup of the inflammatory infiltrate, we
used flow cytometry to assess the quantity and phenotype of
monocytes in the skin at various time points after UVR.
Macrophage numbers increased until D4 in absolute numbers.
By D7, we could not detect any macrophages in the skin using
flow cytometry (Supplementary Figure S1a and b online).
Hence, the macrophage response to UVR shows similar
kinetics to the melanocyte response, both peaking at D4 after
UVR and then diminishing. Costaining of UVR-exposed skin
sections with F4/80 and Ki67 did not suggest proliferation of
macrophages locally, but that the increase is likely to be via
recruitment. Ly6c expression by macrophages has been used
to evaluate the inflammatory status of a mouse tissue
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(Nahrendorf et al., 2007; Cochain et al., 2010). From D2,
Ly6clow ‘‘non-inflammatory’’ macrophages represented
the dominant population, whereas both Ly6clow and Ly6chi
monocytes/macrophages were represented at earlier time
points (Supplementary Results and Supplementary Figure S1c
and d online).
Major histocompatibility complex class II (MHCII) is a
commonly expressed marker with high heterogeneity on
monocytes and macrophages, and it is highly expressed in
macrophages infiltrating human skin after UVR (Meunier
et al., 1995; Ingersoll et al., 2010). Indeed, in UVR-
irradiated mouse skin, MHCII levels discriminated Ly6chi
and Ly6clow macrophages into subpopulations (Figure 2a,
second and third panels, and Figure 2b and c). We observed
a specific increase of the Ly6clowMHCIIhi population between
D2 and D4 (from 16.72 to 40.79%, P¼0.0001; Figure 2d).
This increase was concomitant with the melanocyte response
peaking at D4 (Walker et al., 2009), suggesting a possible link
between the two populations. Using CD11c-DTR/GFP mice,
we established the level of expression of CD11c by each of
the four skin-infiltrating macrophage populations (Supple-
mentary Figure S2 online). In all, 50% of the Ly6clowMHCIIhi
cells expressed CD11c at least at a low level.
Macrophage depletion reduces UVR-induced melanocyte
proliferation/migration
To test whether infiltrating macrophages influence melanocyte
proliferation or migration in vivo, we measured epidermal
melanocyte numbers after macrophage depletion using clo-
dronate-filled liposomes (with phosphate-buffered saline
(PBS)-filled liposomes as controls). To deplete both the local
and systemic recruited subpopulations, liposomes were
injected both intraperitoneally and subcutaneously at 1 day
before UVR (D1), on the day of UVR (D0), and at day 2
(D2) after UVR (Figure 3a). As expected, the clodronate-
treated group showed a significant reduction in macrophage
numbers in the skin, although neutrophils were not affected,
excluding any off-target effect (Figure 3b). On the basis of
Ly6c and MHCII expression, all macrophage populations were
affected by this depletion, although the Ly6clowMHCIIlow
population was less depleted in proportion than the others
(Supplementary Figure S3 online). Most interestingly, in UVB-
irradiated neonates subjected to macrophage depletion, we
observed a significant reduction in the number of interfolli-
cular epidermal melanocytes per mm2 compared with that for
controls injected with PBS (i.e., 32.5 (±1.45) vs. 51.5 (±2.45;
Po0.0001; Figure 3c and d). Clodronate treatment of
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Figure 1. Concurrent increase in epidermal melanocytes and dermal macrophages after neonatal UVB irradiation. (a) Schematic representation of our protocol
of the neonatal irradiation. After harvest, skin was stained with F4/80 or c-KIT antibodies (red) and 4’,6-diamidino-2-phenylindole (DAPI; blue). Control
(UVR)¼ shielded skin, þUVR¼ exposed skin of the same animal. (b, c) Yellow arrows indicate monocytic cells in the dermis. F4/80-positive Langerhans cells
can be seen in the epidermis of nonexposed skin. (d) Isotype control using IgG2 secondary antibody (same for both c-KIT and F4/80). (e, f) c-KIT-positive
melanocytes (red arrows) can be seen at the epidermal basal layer in exposed but not shielded skin. Mast cells are seen as round red cells (green arrows) in the
dermal part of the skin. (g) The number of melanocytes in the skin per microscope field, with and without UVB exposure, 4 days after UVR (D4). N¼ 20–50 fields
from at least 12 pups obtained from independent experiments. Result shown as mean ±SD. ***Po0.001. Scale bars¼ 100mM. Mouse strain background was
C57BL/6J.
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neonates not exposed to UVR did not reduce melanocyte
number, showing that clodronate did not directly affect
melanocytes. As clodronate liposomes target all highly
phagocytic populations, they also depleted populations of
dendritic cells. We therefore used CD11c-DTR/GFP mice
(Jung et al., 2002) to assess the role of dendritic cells in the
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Figure 2. Major histocompatibility complex class II (MHCII) and Ly6c expression levels define skin macrophage populations with different infiltration patterns.
(a) The first panel shows gating of CD11bhi/Ly6glow macrophages. The second and third panels show the relative proportions of the macrophage populations based
on Ly6c and MHCII staining at day 2 (D2) and day 4 (D4) after UVR, respectively. (b) Representation of the proportion of macrophages based on Ly6c. SIM,
skin-infiltrating macrophage. (c) MHCII or (d) both Ly6c and MHCII levels of expression. N¼8–9 pups for each time point and is representative of two
independent experiments. Results shown as mean±SD. ***Po0.001.
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Figure 3. Macrophage depletion but not CD11cþ cell depletion decreases melanocyte response to UVR. (a) Schematic protocol of irradiation and injection of
clodronate to neonates. (b) Representation of the effect of clodronate injection on macrophages and neutrophils. (c) More c-KIT-positive melanocytes (white
arrows) in control UVB-irradiated skin, compared with irradiated skin treated with clodronate. (d) Melanocyte counts per field in UVB-irradiated skin (no UVR for
control), with clodronate or phosphate-buffered saline (PBS) treatment. N¼ 5–8 pups for each group from two independent experiments. CD11c-DTR/GFP mice
were injected with diphtheria toxin or PBS at 1 day before UVR (D 1), on the day of UVR (D0), and at day 2 (D2) after UV exposure. Skin was collected at day 3
(D3). (e) Number of green fluorescent protein (GFP) cells to show the depletion dendritic cells. (f) Melanocyte response was evaluated in depleted (n¼ 3) and
control (n¼ 5) mice. Results represent pooled data from two independent experiments. Cld, clodronate; D, depleted, DAPI, 4’,6-diamidino-2-phenylindole; i.p.,
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context of UVR and melanocyte response. Despite efficient
depletion in neonates (significant reduction in the number of
GFPþ cells per field), the epidermal melanocyte density
after UVR was similar to neonates that were not depleted
(Figure 3e and f).
Characterization of the UVB-induced inflammation by
expression profiling
Having confirmed the role of UVR-induced macrophages in
the skin in promoting melanocyte proliferation, we next
addressed the question of potential mechanisms. To ask what
may be released in the epidermis after UVR to attract
macrophages into the skin, we performed gene expression
array analysis on UVR-treated epidermis. Melanocyte num-
bers increase at D2 after UVR (Walker et al., 2009); therefore,
the necessary stimulus is probably present much earlier. Thus,
we selected 6, 10, and 24 hours, and D3 after UVR, using
three pups per time point. As gene expression in the neonatal
epidermis is dynamic over time even without UVR, we used
shielded skin as control (i.e., each mouse is its own control).
Thus, our results are not skewed by normal developmental
gene expression changes that occur in the pups over the 72-
hour period (detailed in Supplementary Results and
Supplementary Table S1 online).
Examination of earlier time points (6, 10, and 24 hours after
UVR) revealed the potential role of immune-related genes.
Defensins (DEFb4 and DEFb14) showed a significant upregu-
lation after UVR. DEFb4 has been shown to induce macro-
phage infiltration, possibly by binding the macrophage CCR2
or Toll-like receptors (TLRs) (Ro¨hrl et al., 2010). In human
epidermis, b-defensin is upregulated over 50-fold after UVR
exposure (Enk et al., 2006), and in the context of melanocyte
activation it may be another ligand (in addition to agouti
signaling peptide (ASIP)) for the melanocortin 1 receptor
(MC1R), a receptor whose deregulation is important in
melanoma (Candille et al., 2007; Beaumont et al., 2012;
Swope et al., 2012). Interestingly, other cytokines were
significantly transcriptionally upregulated in the neonatal
skin by UVR exposure, including IL-33 and tumor necrosis
factor-a (TNF-a). The former has been shown to induce
inflammatory macrophage infiltration (Kurowska-Stolarska
et al., 2009). In summary, despite the limitations of gene
expression array studies on mixed cell populations in the
epidermis, our results point to major changes in immune
regulation in exposed skin.
CCR2-negative Ly6clowMHCIIhi macrophages promote the
melanocyte response in part through IL-17
We then set out to further dissect the molecular mechanism of
the promotion of the neonatal melanocyte response by
macrophages. In light of our expression array findings, we
studied melanocyte behavior in mice deficient for key cells
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Figure 4. Ly6clowMHCIIhimacrophages promote melanocyte response to UVR. (a) The number of melanocytes per field in UVB-exposed skin from wild-type (WT)
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and molecules involved in the inflammation process. First, we
measured the melanocyte response in RAG1 / mice and
found it to be the same as in wild-type (WT) mice (C57Bl/6J),
essentially ruling out a significant role of T or B lymphocytes
in this response (Figure 4a).
We next considered CCR2, a major chemokine receptor
involved in macrophage recruitment. Surprisingly, the number
of epidermal melanocytes was higher in the CCR2 / mice
than in WT pups (68.8 vs. 55.25, Po0.0001; Figure 4a).
Furthermore, the total number of skin-infiltrating macrophages
was not decreased in CCR2 / mice compared with WT at
any time point after UVR, as measured by either flow
cytometry or F4/80 staining of skin sections. However, flow
cytometry analyses at D1 after UVR revealed a marked defect
in the recruitment of the initial Ly6chi inflammatory popula-
tion, known to be CCR2-positive cells (Geissmann et al.,
2003), in the CCR2 / mice compared with WT (Figure 4b).
By D4, the proportion of Ly6chi and Ly6clow macrophages was
the same between WT and CCR2 / mice, and the macro-
phage infiltration into the skin in response to UVR mainly
comprised the CCR2-independent cell population.
Defensins have been described to activate myeloid cells
through TLRs (Biragyn et al., 2008; Semple et al., 2011). We
therefore postulated that the regulation of the melanocyte
response by skin-infiltrating macrophages might be MyD88/
TRIF (myeloid differentiation primary response gene (88)/TIR-
domain-containing adapter-inducing interferon-b) dependent
as the main downstream signaling molecules associated with
TLRs. Similarly, the increased expression of TNFa and IL33
prompted us to consider their role in the activation of
macrophages and therefore in the melanocyte response.
Consequently, we compared the melanocyte response in
WT, ST2 (IL33R / ), TNFa / , and MyD88/TRIF / mice
(Figure 4a). The absence of any difference in epidermal
melanocyte counts clearly showed that none of these path-
ways/molecules alone was important for the melanocyte
response to UVR.
Finally, we considered inflammatory cytokines usually
produced by effectors such as IL-17 and IFN-g. The significant
increase in b-defensin, as well as S100A8 or S100A9 tran-
scription in the epidermis, after UVR could reflect a response
to IL-17, as previously described in the lung and skin epithelia
(Kao et al., 2004; Kryczek et al., 2008). In accordance,
IL17 / mice showed a 15% decrease in the number of
interfollicular epidermal melanocytes when compared with
WT mice, suggesting a role for IL-17 possibly in the
melanocyte response to UVR. We did not observe any
significant effect in IFNg / mice.
We next analyzed, by flow cytometry, the macrophage
subpopulations infiltrating the skin in the IL17 / , CCR2 / ,
and WT mice at D4 after UVR (Figure 4c). Surprisingly, in
CCR2 / mice, despite the marked reduction in CCR2-
dependent ‘‘inflammatory’’ infiltrate at 24 hours, the propor-
tion of Ly6clowMHCIIhi macrophages was higher at 4 days
after UVR compared with WT (1.37-fold; 56±12.8 vs.
40.8±5.9%). In contrast, it was significantly decreased in
IL17 / mice, by 0.61-fold (25.2±6.6%; Po0.05 for all
comparisons with WT using Mann–Whitney test). In addition,
linear regression analysis revealed a strong positive correlation
between the melanocyte response and the proportion of the
Ly6clowMHCIIhi macrophages in WT, IL17 / , and CCR2 /
mice (Figure 4d; r2¼0.69, Po0.001), further suggesting that
Ly6clowMHCIIhi cells contribute to the melanocyte response.
DISCUSSION
The neonatal period is critical in terms of inducing MM in
mice using UVR (Noonan et al., 2001). Exposure during this
period induces a melanocyte proliferative and migratory
response, as reflected by their presence in the interfollicular
epidermis and the upper portion of the hair follicle. Suspecting
an important role for the inflammatory component of the UVR
response in driving melanocyte proliferation and migration,
we have described the kinetics of macrophage infiltration into
the skin using multicolor flow cytometry. We then used a
macrophage depletion strategy to demonstrate functionally the
existence of a macrophage–melanocyte link. Using a number
of mouse models with various inflammatory defects, we
established that this melanocyte response is dependent upon
infiltrating CCR2-negative macrophages and, in part, depen-
dent on IL-17.
Macrophages are known to be a heterogeneous population
that increases in size partly from the recruitment of circulating
monocytes to sites of inflammation. During macrophage
infiltration, a transition from mainly Ly6chi to mainly Ly6clow
cells has been proposed to reflect the resolution of the
inflammation (Geissmann et al., 2003; Nahrendorf et al.,
2007; Cochain et al., 2010). In our model, the recruited
Ly6chi macrophages reached a peak at D1 after UVR and
returned to their steady-state proportion at D2. This would
support the notion of an early classical inflammatory response
after neonatal UVR via recruitment of Ly6chi CCR2–positive
monocytes that mostly ceases after D1. This early transition
from Ly6chi to Ly6clow within the first 24 hours seems to be
specific to UVR when compared with other inflammatory
situations. However, the number of macrophages continued to
increase between D1 and D4 without significant proliferation,
suggesting additional recruitment of mostly Ly6clow cells,
reported to be CCR2 negative (Geissmann et al., 2003).
In vivo, macrophages are reported to be heterogeneous, and
it can be challenging to discriminate subpopulations on the
basis of function (Sica and Mantovani, 2012). We (Rodero
et al., 2012) and others (Movahedi et al., 2010) have used
both Ly6c and MHCII expression levels to discriminate
macrophage populations, which in the context of wound
healing and tumor progression exhibit distinct recruitment
patterns and transcriptomic profiles. Specifically, using these
markers in UVR-induced inflammation, we could identify two
distinct populations among the Ly6clow macrophages, with
distinct recruitment patterns. It remains, however, unclear
whether Ly6clow MHCIIlow and Ly6clow MHCIIhi arise from
distinct myeloid precursors or instead reflect distinct levels of
activation in cells that have a common precursor. Although
we cannot exclude minor roles for other populations, our
results strongly suggest that the melanocyte response is due to
the activity of Ly6clowMHCIIhi macrophages. This is supported
by the correlation between increased Ly6clowMHCIIhi
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population and melanocyte number over time in several
different strains of mice. Moreover, our data further suggest
that the CD11c -negative fraction of this Ly6clowMHCIIhi
population is enough to promote the melanocyte response,
as we do not observe any effect after CD11cþ cell depletion.
This particular macrophage population can also promote
tumor growth by inducing T-cell immunosuppression
(Movahedi et al., 2010). Altogether, our results imply that
neonatal UVR results in the recruitment of a population of
macrophages that promote melanocyte proliferation and
possibly tumor progression (Zaidi et al., 2011), although the
latter needs to be formally demonstrated.
The use of clodronate liposomes has clarified the impor-
tance of macrophages in a range of disorders. In our model,
clodronate liposomes depleted macrophages without affecting
other myeloid populations such as neutrophils or mast cells.
Liposome uptake is known to essentially target highly phago-
cytic cells. As shown in our results, it did not affect all
macrophage populations equally, and the depletion was not
complete. This could explain the incomplete suppression of
the melanocyte response. Alternatively, other parallel
mechanisms independent of macrophages might exist to
promote the melanocyte response to UVR in neonates.
However, the lack of effect on this response observed after
depletion of CD11cþ cells clearly excludes a role for
Langerhans and dermal dendritic cells.
Having demonstrated the importance of macrophages, we
next sought to understand the mechanisms involved in the
neonatal melanocyte response. We did not observe any defect
in the melanocyte response to UVR in IFNg / or in
TNFa / mice, suggesting that it is not the classical T helper
type 1 inflammatory cytokines that link macrophage and
melanocyte responses to UVR.
TLRs are an important pathway in innate immunity and
macrophage activation. The increased expression of defensins
in the epidermis in our gene expression array also pointed to
these receptors as a way of activating recruited macrophages.
The increased expression of IL-33, an IL-1 family member,
could represent an alternative. All TLRs, as well as the IL-33R,
signal through MyD88 and/or TRIF. The normal melanocyte
response in MyD88/TRIF / mice, as well as in ST2
(IL33R / ) mice, clearly excludes the importance of these
pathways. Finally, we observed a small but significant
reduction of the melanocyte response in IL17 / mice.
Interestingly, Kotobuki et al. (2012) recently proposed a role
for IL-17 in the inhibition of human melanocyte activity. They
showed that direct treatment of human melanocytes with
IL-17 reduced MITF (microphthalmia-associated transcription
factor) and Bcl-2 (B-cell lymphoma 2) expression and
diminished pigment production activity. However, in our
setting, IL-17 may help activate melanocyte activity, at least
in terms of proliferation or migration, which Kotobuki et al.
(2012) did not measure. In addition, our data suggest an
indirect role for IL-17 in the context of UVR-induced
melanocyte activation. As IL-17 receptors are widely
expressed, it is not clear as to how IL-17 mediates its effect;
it could be at any level from epidermal cell activation to the
recruitment and activation of macrophages.
The lack of effect observed in the knockout mice
mentioned above does not imply that these pathways are
not involved in the melanocyte response, rather that they are
not exclusive and necessary. This may be one reason why our
study is not suggestive of an IFN-g-mediated mechanism
driving the melanocyte response, as reported by Zaidi et al.
(2011). Other differences between their study and ours include
the postnatal timing of UVR exposure (P1 vs. P3 in our study),
the time between exposure and melanocyte counting (D7 vs.
D4 in our study), the mouse strain background (FVB vs.
C57BL/6J in our study), and the mode of blocking
IFN signaling within the skin (anti-IFN-g antibody vs.
IFN-g-knockout mice). Despite these differences in the
implicated cytokine (possibly due to the caveats just
mentioned), both studies point to a critical role of
macrophages in the melanocyte response to UVB used at
ostensibly equivalent doses, and both have excluded the
capacity of UVA to provoke a similar response (Walker
et al., 2009; Zaidi et al., 2011).
We do not believe that the activity of macrophages can
explain all of the melanocyte proliferation. Other cell types
within the skin, particularly keratinocytes, can have a marked
influence on melanocyte behavior, including their positioning
in the epidermis. This has been shown in mouse models
carrying specific mutations. For instance, mutation of KRT2E
or EGF (Fitch et al., 2003), Integrin b1 (Lo´pez-Rovira et al.,
2005), or b-Catenin (Rabbani et al., 2011) in keratinocytes can
also increase epidermal melanocyte density. The mechanism
involved in the latter case is proposed to involve increased
keratinocyte EDN1 expression that may drive melanocyte
proliferation or migration. Overexpression of keratinocyte
KITL (or stem cell factor) also supports the localization of
melanocytes in the murine interfollicular epidermis, either by
transgenic overexpression of the membrane-bound form
(Kunisada et al., 1998) or indirectly by upregulation of p53,
which increases KITL transcription in the epidermis (Box and
Terzian, 2008). FGF2 upregulation can also induce the
activation of melanocytes (Weiner et al., 2007). However,
we did not observe a significant upregulation of endothelins,
KITL, or FGF2 in our expression array analysis of the epidermis
after UVR. The chemokine CXCL12 (chemokine (C-X-C motif)
ligand 12) regulates the migration of melanocyte progenitors
downward from the stem cell niche during anagen (Belmadani
et al., 2009), but there is no evidence to date that it influences
our observed upward migration in the neonatal setting in
response to UVR. The above-mentioned molecules that either
emanate from keratinocytes or influence keratinocyte
differentiation status are among the very few shown to
promote melanocyte migration and proliferation in vivo. We
note that prostaglandin E synthase is upregulated at all time
points. Prostaglandin E2 and prostaglandin F2a released from
keratinocytes have been shown to stimulate dendrite
formation in melanocytes in culture (Scott et al., 2004),
suggesting a possible mechanism to investigate in future
experiments.
The melanocyte proliferation and migration in neonates in
response to UVR (Walker et al., 2009) is not seen in adult skin
after a single comparable dose of UVR, and hence is
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ostensibly specific to the neonatal periods when UVB expo-
sure is known to markedly exacerbate MM development in
mice (Noonan et al., 2001). We suspect that this is because
neonatal melanocytes are extremely sensitive to UVR, as
chronic UVR seems to be necessary to increase the number
of epidermal melanocytes in adult mice (Aoki and Moro,
2005). Innate responses of the skin to neonatal UVR may
provide useful information for MM given that the most
common subtypes (nodular or superficial spreading MM)
appear to be associated with acute sunburns (Gandini et al.,
2005), particularly those associated with childhood sun
exposure (Whiteman et al., 2001). Although neonatal mouse
skin may represent a somewhat specialized system, a single
burning dose of UVR to human skin also promotes a strong
influx of macrophages (Meunier et al., 1995). Additional
evidence links the melanocyte response with carcinogenesis.
The number of active melanocytes in 2-week-old mouse
epidermis is greatly increased by chemical carcinogen
application, and the more carcinogenic the compound, the
greater the effect (Iwata et al., 1981). Strong liver carcinogens
that are not metabolically activated in skin were ineffective.
The compound most effective in inducing melanocyte
proliferation was 7,12-dimethylbenz(a)anthracene, a very
potent skin carcinogen. Thus, the melanocyte activation is
driven either by UVR or by compounds that induce adducts
within the DNA of skin cells, both of which can induce
melanoma (Iwata et al., 1981; Sharov et al., 2003).
To conclude, in this work, we have functionally verified the
important role of macrophages in the melanocyte response to
UVR. Using mice genetically deficient for a range of pathways
and cytokines, we establish that the melanocyte response is
not dependent upon the TNF-a, IFN-g, IL-33R, or TLR ligand
activation pathways, but can be reduced by ablation of IL-17.
After a detailed examination of the macrophage populations
infiltrating neonatal skin after UVR, we have established that
the CCR2-independent recruitment of Ly6cloMHCIIhiCD11c-
macrophages is positively correlated with the extent
of the melanocyte response. We believe that this work may
have important implications in terms of establishing the
type of immune environment required for UVR-mediated
promotion of melanoma (Wolnicka-Glubisz et al. 2007;
McGee et al., 2011).
MATERIALS AND METHODS
UVR treatments
Treatments were performed as previously described (Walker et al.,
2009). Full details are available in the Supplementary Methods
online.
Immunofluorescence and flow cytometry staining
Immunofluorescence staining was performed as reported in Walker
et al. (2009), and flow cytometry as described in Rodero et al. (2012).
Full details are available in the Supplementary Methods online.
Skin collection and RNA extraction
After UVR exposure, three pups were killed at each time point. The
epidermis was separated from the dermis by floating them in a
mixture of thermolysine and CaCl2 in PBS at 37 1C for 2 hours. The
epidermis was transferred immediately to RNAlater (AMBION,
Austin, TX) and stored at  20 1C before use. The RNA extraction
was carried out according to the Qiagen RNeasy Mini protocol
(QIAGEN, Mannheim, Germany).
Mouse expression array
From each epidermis, 500 ng of total RNA was used as the starting
material to produce cRNA, according to the Illumina TotalPrep RNA
Amplification protocol (Illumina, San Diego, CA). From each sample,
1,500 ng of cRNA was hybridized to Illumina MouseWG-6 v2.0
Expression BeadChips (Illumina) and then scanned. Data were
extracted using GenomeStudio (Illumina, San Diego, CA) and then
imported into GeneSpring GX 11.5.1 (Agilent Technologies, Santa
Clara, CA), before normalization using the quantile algorithm and
subsequent analysis.
Clodronate treatment to specifically deplete macrophages
Clondronate (Cl2MDP, a gift of Roche Diagnostics GmbH, Man-
nheim, Germany) or PBS was encapsulated in liposomes containing
phosphatidylcholine (Lipoid GmbH, Ludwigshafen, Germany) and
cholesterol (Sigma-Aldrich, St Louis, MO), as described previously
(Van Rooijen and Sanders, 1994). Pups were injected with 5 mg ml 1
clodronate (clodronic acid)- or PBS (control)-filled liposome
suspension, 30ml intraperitoneally and 30ml subcutaneously, on the
day before UVR (D 1), the day of UVR (D0), and 2 days after UVR
(D2) exposure. Skin was harvested on D3.
Knockout mice
The knockout mice used in this study were as follows: CCR2 /
(Boring et al., 1997), IFNg / (Dalton et al., 1993), IL17 / (Nakae
et al., 2002), ST2 (IL33R / ) (Townsend et al., 2000), MyD88/TRIF /
(Hoebe et al., 2003), RAG1 / (Mombaerts et al., 1992), and
TNFa / (Pasparakis et al., 1996). All mice, as well as WT con-
trols, were on a C57BL/6J background. All animals are kept in a
modern Optimice caging system (Centennial, CO), under the care of
trained animal handlers. The work was approved by the Queensland
Institute of Medical Research Animal Ethics Committee (A98004M).
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